Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Tāmaki Health appoints advisers amid investor interest
Health

Tāmaki Health appoints advisers amid investor interest

The company's received numerous approaches from interested parties, CEO says.

John Anthony 25 Jul 2025
Why Promisia's promised land is Cromwell
Retail Small Cap Wrap

Why Promisia's promised land is Cromwell

Plus chicken and eggs with BlackPearl, Rua goes for gold in Reefton, and more.

Health NZ approves AI scribes
Health

Health NZ approves AI scribes

Patients will be asked for consent when clinicians are trialling AI in consultations.

John Anthony 14 Jul 2025